CONMED Begin Period Cash Flow Over Time
| CNMD Stock | USD 77.54 2.63 3.51% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out CONMED Performance and CONMED Correlation. CONMED |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CONMED. If investors know CONMED will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CONMED listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.14 | Dividend Share 0.8 | Earnings Share 4.37 | Revenue Per Share 41.821 | Quarterly Revenue Growth 0.04 |
The market value of CONMED is measured differently than its book value, which is the value of CONMED that is recorded on the company's balance sheet. Investors also form their own opinion of CONMED's value that differs from its market value or its book value, called intrinsic value, which is CONMED's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CONMED's market value can be influenced by many factors that don't directly affect CONMED's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CONMED's value and its price as these two are different measures arrived at by different means. Investors typically determine if CONMED is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CONMED's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Begin Period Cash Flow Analysis
Compare CONMED and related stocks such as NuVasive, Orthopediatrics Corp, and Pulmonx Corp Begin Period Cash Flow Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KIDS | 58 K | 58 K | 58 K | 58 K | 58 K | 6.6 M | 3.9 M | 1.6 M | 42.6 M | 60.7 M | 72 M | 30.1 M | 9 M | 10.5 M | 9.9 M |
| LUNG | 10.1 M | 10.1 M | 10.1 M | 10.1 M | 10.1 M | 10.1 M | 10.1 M | 10.1 M | 10.1 M | 4.1 M | 14.8 M | 231.8 M | 148.7 M | 102 M | 93.8 M |
| SIBN | 12.5 M | 12.5 M | 12.5 M | 1.8 M | 8.5 M | 17.6 M | 20.3 M | 27.9 M | 22.4 M | 25.1 M | 10.4 M | 53.6 M | 63.4 M | 20.7 M | 26.1 M |
| GMED | 44.7 M | 111.7 M | 142.7 M | 212.4 M | 90 M | 82.3 M | 60.2 M | 67 M | 118.8 M | 139.7 M | 195.7 M | 239.4 M | 193.1 M | 150.5 M | 139.2 M |
| OFIX | 200 K | 13.6 M | 33.2 M | 31.1 M | 28.9 M | 36.8 M | 63.7 M | 39.6 M | 81.2 M | 72.2 M | 70.4 M | 96.8 M | 87.8 M | 50.7 M | 38.6 M |
| ATEC | 753.9 K | 23.2 M | 20.7 M | 22.2 M | 21.3 M | 19.7 M | 11.2 M | 19.8 M | 22.5 M | 29.1 M | 47.1 M | 107.8 M | 187.2 M | 84.7 M | 88.9 M |
| LIVN | 3.4 M | 89.3 M | 96.7 M | 120.7 M | 103.3 M | 124.2 M | 112.6 M | 39.8 M | 93.6 M | 47.2 M | 61.1 M | 252.8 M | 208 M | 515.6 M | 541.4 M |
| ITGR | 4.1 M | 22.9 M | 36.5 M | 20.3 M | 35.5 M | 76.8 M | 82.5 M | 52.1 M | 44.1 M | 25.6 M | 13.5 M | 49.2 M | 17.9 M | 24.3 M | 40.6 M |
| IRTC | 7.1 M | 7.1 M | 7.1 M | 7.1 M | 7.1 M | 8.6 M | 25.2 M | 51.6 M | 8.7 M | 20 M | 20.5 M | 88.6 M | 127.6 M | 78.8 M | 48 M |
| SRDX | 500 K | 23.2 M | 15.5 M | 15.5 M | 43.5 M | 55.6 M | 25 M | 16.5 M | 23.7 M | 30.4 M | 30.8 M | 31.2 M | 19 M | 41.4 M | 43.5 M |
| SGHT | 7.1 M | 7.1 M | 7.1 M | 7.1 M | 7.1 M | 7.1 M | 7.1 M | 7.1 M | 7.1 M | 4.2 M | 21.2 M | 61.5 M | 260.7 M | 185 M | 99 M |
| GKOS | 5.6 M | 5.6 M | 5.6 M | 1.7 M | 6.7 M | 2.3 M | 21.6 M | 6.5 M | 24.5 M | 38.6 M | 71.8 M | 106.2 M | 110.1 M | 126.6 M | 132.9 M |
| STE | 400 K | 193 M | 150.8 M | 142 M | 152.8 M | 167.7 M | 248.8 M | 282.9 M | 201.5 M | 220.6 M | 319.6 M | 220.5 M | 348.3 M | 208.4 M | 124 M |
| ANIK | 5.1 M | 28.2 M | 35.8 M | 44.1 M | 63.3 M | 100.2 M | 110.7 M | 104.3 M | 133.3 M | 89 M | 157.5 M | 95.8 M | 94.4 M | 86.3 M | 54.1 M |
CONMED and related stocks such as NuVasive, Orthopediatrics Corp, and Pulmonx Corp Begin Period Cash Flow description
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.My Equities
My Current Equities and Potential Positions
| CONMED | CNMD |
Specialization | Health Care, Health Care Equipment & Services |
| Location | New York; U.S.A |
| Exchange | New York Stock Exchange |
USD 77.54
Check out CONMED Performance and CONMED Correlation. For information on how to trade CONMED Stock refer to our How to Trade CONMED Stock guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
CONMED technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.